SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Amati investors
AMTX 1.635-0.9%2:02 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Chemsync who wrote (29019)11/20/1997 4:12:00 PM
From: Andreas Helke  Read Replies (2) of 31386
 
My replacement for Amati with similar upside potential and price volatility is Ligand Pharma (LGND). They have a amazingly good pipeline of potential medicaments and hopefully a bright future. And in contrast to Amati where a lot of the good future was already in the stock price, Ligand is seriously undervalued if compared with many other biotechs. And in contrast to Amati Ligand probably has enough cash and income from partners to last till expected profitability in 1999.

Andreas
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News